Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug
The Danish company and AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived.
Connecting Global Economies
Flash News
Barbie maker Mattel faces investor pressure to consider sale
Lala Kent’s Go-to Eye Patches for a “Little Lift” Are on Sale for Prime Day
The price tag on the Ken Paxton rescue mission has Republicans panicking
Fintech Plaid Bets on Credit Scores to Fuel Next Phase of Growth
Breaking | Francis Halzen wins 2026 Nobel Prize in Physics
Yemen forces reclaim Red Sea port city of Mokha from Houthis
The Secrets of Faith Hill and Tim McGraw’s Inspiring Love Story
Ken Paxton’s secret weapon: Ted Cruz
Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug
Germany joins France in call for China trade defences
Tuesday, October 06, 2026